Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity
Panagiotis Efentakis, Angelina Choustoulaki, Ioannis V. Kostopoulos, Aimilia Varela, Anastasios D. Georgoulis, George Tsekenis, Charikleia Gakiopoulou, Ioannis Ntanasis‐Stathopoulos, Constantinos H. Davos, O.E. Tsitsiloni, Meletios A Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou, Ioanna Andreadou (2023). Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity. , 44(Supplement_2), DOI: https://doi.org/10.1093/eurheartj/ehad655.770.
